ORIGINAL RESEARCH article

Front. Malar.

Sec. Vectors

Volume 3 - 2025 | doi: 10.3389/fmala.2025.1609614

This article is part of the Research TopicAddressing Contemporary Threats to Global Malaria Control: New Tools and StrategiesView all 11 articles

Impact of artemether-lumefantrine treatment, circadian rhythm and serum replacement on the infectiousness of wild P. falciparum gametocytes to An. gambiae sensu stricto mosquitoes

Provisionally accepted
Dorin  Joachim MmasiDorin Joachim Mmasi1,2*Prisca  KweyambaPrisca Kweyamba1,3,4Fatuma  MatweweFatuma Matwewe1Masudi  Suleiman MaasayiMasudi Suleiman Maasayi1Nolvin  J MvungiNolvin J Mvungi1Ummi  Abdul KibondoUmmi Abdul Kibondo1Tibebu  HabtewoldTibebu Habtewold1,5Jennifer  C StevensonJennifer C Stevenson1,3,4Lorenz  Martin HoferLorenz Martin Hofer1,3,4Sarah  Jane MooreSarah Jane Moore1,2,3,4Mgeni  M TambweMgeni M Tambwe1,2
  • 1Ifakara Health Institute, Ifakara, Tanzania
  • 2Nelson Mandela African Institution of Science and Technology, Arusha, Arusha, Tanzania
  • 3Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Basel-Landschaft, Switzerland
  • 4University of Basel, Basel, Switzerland
  • 5Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, England, United Kingdom

The final, formatted version of the article will be published soon.

Background: In the era of asymptomatic gametocytaemia, participants are scarce but serve as key reservoirs for Plasmodium falciparum gametocytes. Transmission-blocking interventions (TBIs) are gaining attention, taking into account factors such as artemether-lumefantrine (AL) treatment, mosquito feeding time (day vs. night), and serum replacement, recognised for their potential in influencing Direct Membrane Feeding Assay (DMFA) outcomes and reduce assay precision. This study aimed to assess the effect of optimising DMFA towards re using gametocytemic participants (1) prior artemether-lumefantrine treatment, (2) mosquito feeding time, and (3) serum replacement on gametocyte infectiousness to mosquitoes in a low malaria transmission setting.Methods: Six gametocytemic participants found to be eligible and donated 4 mL of venous blood. This blood was offered to female Anopheles gambiae sensu stricto (ss) mosquitoes via DMFA under controlled conditions. Oocyst prevalence and intensity was determined on fed mosquitoes: 1) 9 days post AL treatment 2) for day feeds versus night feeds and 3) with and without serum replacement. Results: Mosquito infection rates declined post-AL treatment, with significantly fewer mosquitoes infected (odds ratio (OR) = 0.20, 95% confidence interval (CI) = 0.13-0.31, p=0.001) compared to day 0. Feeding during the mosquito dark cycle time did not significantly affect mosquito infection rates (OR=0.77, 95% CI: 0.53-1.12, p=0.175). Lastly, serum replacement increased infection rates (OR = 1.73, 95% CI: 1.33-2.25, p = 0.001) compared to whole blood. Conclusion: To obtain robust results we confirm that DMFA should be conducted using blood from gametocytemic participants without a recent history of AL treatment, using serum replacement to enhance infection success. In this setting, assays could be conducted outside of the mosquito dark cycle without affecting results.

Keywords: DMFA, aL, TBIs, Anopheles gambiae ss, gametocytes, Oocysts, asymptomatic Left

Received: 10 Apr 2025; Accepted: 09 Jun 2025.

Copyright: © 2025 Mmasi, Kweyamba, Matwewe, Maasayi, Mvungi, Kibondo, Habtewold, Stevenson, Hofer, Moore and Tambwe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dorin Joachim Mmasi, Ifakara Health Institute, Ifakara, 78 373, Tanzania

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.